Lorenzo Canti is a Post-Doctoral Fellow in the Bond Life Sciences Center at University of Missouri from March 2024. In February, he received his PhD in Biomedical Sciences from University of Liège with a thesis on the study of the immune response of allo-HSCT patients immunized with the BNT162b2 vaccine. Lorenzo’s research focuses on “immune imprinting”, i.e. the effect of repeated vaccination against pathogenic viruses, primarily those of the influenza.